Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
7.10
+0.03 (0.42%)
Mar 31, 2025, 12:07 PM EDT - Market open

Contineum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.9415.535.574.63
Short-Term Investments
182.82109.6641.6764.37
Cash & Short-Term Investments
204.76125.1947.2469
Cash Growth
63.56%165.01%-31.54%-
Prepaid Expenses
1.632.521.150.78
Total Current Assets
206.39127.7148.3969.78
Property, Plant & Equipment
6.461.42.120.64
Other Long-Term Assets
01.280.130.1
Total Assets
212.85130.3950.6470.52
Accounts Payable
1.810.640.430.66
Accrued Expenses
6.714.392.061.69
Current Portion of Long-Term Debt
--3.951.25
Current Portion of Leases
1.450.461.11-
Other Current Liabilities
---0.08
Total Current Liabilities
9.975.487.553.67
Long-Term Debt
---3.66
Long-Term Leases
4.810.110.79-
Other Long-Term Liabilities
-0.113.031.6
Total Liabilities
14.785.711.378.93
Common Stock
0.0300.010.01
Additional Paid-In Capital
315.377.14.722.74
Retained Earnings
-117.4-75.14-97.86-73.61
Comprehensive Income & Other
0.070.11-0.08-0.04
Total Common Equity
198.07-67.94-93.21-70.89
Shareholders' Equity
198.07124.6839.2761.59
Total Liabilities & Equity
212.85130.3950.6470.52
Total Debt
6.260.575.854.91
Net Cash (Debt)
198.5124.6241.3964.1
Net Cash Growth
59.29%201.08%-35.42%-
Net Cash Per Share
10.2636.7018.4530.39
Filing Date Shares Outstanding
25.872.352.262.11
Total Common Shares Outstanding
25.852.352.262.11
Working Capital
196.41122.2240.8466.11
Book Value Per Share
7.66-28.91-41.25-33.61
Tangible Book Value
198.07-67.94-93.21-70.89
Tangible Book Value Per Share
7.66-28.91-41.25-33.61
Machinery
2.532.111.691.58
Leasehold Improvements
0.180.050.020.02
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q